drugset / Trial / NCT00091299

Warfarin and Vatalanib in Treating Patients With Advanced Solid Tumors

NCT00091299 ↗

NaSingle-groupOpen-labelTreatment

Summary

RATIONALE: Vatalanib may stop the growth of tumor cells by stopping blood flow to the tumor. Warfarin may be effective in preventing the formation of blood clots in patients who are undergoing treatment for advanced solid tumors. PURPOSE: This phase I trial is studying how well giving warfarin together with vatalanib works in treating patients with advanced solid tumors.

Timeline

Start
2004-05
Primary completion
2012-08
Completion
2012-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Warfarin Small molecule — Oral